Release Date: 31/10/17 08:18 Summary: Addendum to the Annual Report - Reserves Statement Price Sensitive: Yes Download Document 359.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%